Best Buy Co Inc vs Cassava Sciences Inc — how do they compare? Best Buy Co Inc trades at $83.5 (market cap $17.55B), while Cassava Sciences Inc trades at $0.97 (market cap $47.75M). The key difference: Best Buy Co Inc is far larger — about 367.5× Cassava Sciences Inc's market cap, and Best Buy Co Inc pays a 4.61% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.
| BBY | FLNA | |
|---|---|---|
Market Cap | $17.55B | $47.75M |
Sector | Consumer Cyclical | Health |
52-Week High | $90.17 | $4.64 |
52-Week Low | $55.52 | $0.87 |
Enterprise Value | $19.93B | -$34.93M |
Dividend Yield | 4.61% | — |
Trailing returns across standard periods
Latest headlines on both assets
With $51.8 billion in fiscal 2022 sales, Best Buy is the largest pure-play consumer electronics retailer in the U.S., with roughly 10.6% share of the aggregate market and north of 40% share of offline sales, per our calculations, CTA industry, and Euromonitor data. The firm generates the bulk of its sales in-store, with mobile phones and tablets, computers, and appliances representing its three largest categories. Recent investments in e-commerce fulfillment, accelerated by the COVID-19 pandemic, have seen the U.S. e-commerce channel roughly double from prepandemic levels, with management estimating that it will represent a mid-30% proportion of sales moving forward.
Read more on BBY →Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →